openPR Logo
Press release

United States Infertility Treatment Market valuation $6,009.58 million by 2033 - Exclusive Report by DatamIntelligence

10-10-2025 01:34 PM CET | Health & Medicine

Press release from: DataM intelligence 4 Market Research LLP

Infertility Treatment Market

Infertility Treatment Market

"Infertility Treatment Market size was valued at USD 2,981.35 million in 2024 and is estimated to reach USD 6,009.58 million in 2033 at a compound annual growth rate (CAGR) of 8.10% over the forecast period 2025-2033." As per DataM intelligence research report

Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/infertility-treatment-market?sp

United States: Recent Industry Developments

✅ In September 2025, Ferring Pharmaceuticals launched a next-generation injectable therapy for female infertility, improving ovarian response and IVF success rates.

✅ In August 2025, Progyny expanded its fertility benefits platform with AI-driven personalized treatment plans and predictive analytics to optimize IVF outcomes for patients.

✅ In July 2025, CooperSurgical introduced an advanced embryo culture system that enhances implantation success and embryo viability, supporting assisted reproductive technologies.

✅ In June 2025, Johnson & Johnson invested $100 million in R&D for innovative male infertility therapies, including next-generation sperm selection and motility enhancement technologies.

Japan: Recent Industry Developments

✅ In September 2025, Terumo Corporation launched a new culture medium for IVF treatments, improving embryo development and implantation success rates.

✅ In August 2025, FUJIFILM Wako Pure Chemical Industries introduced AI-based embryo selection software for Japanese fertility clinics, enhancing IVF precision and outcomes.

✅ In July 2025, Otsuka Pharmaceutical initiated clinical trials for a novel oral therapy addressing endometriosis-related infertility in women.

✅ In June 2025, Kyowa Kirin expanded its fertility treatment portfolio with biologics targeting hormonal regulation for improved ovulation and conception rates.

Infertility Treatment Market: Drivers

The infertility treatment market is experiencing rapid growth driven by rising prevalence of reproductive health issues and increasing awareness about fertility solutions. Assisted reproductive technologies (ART), including in-vitro fertilization (IVF) and intrauterine insemination (IUI), are increasingly adopted to address male and female infertility. Advances in diagnostic tools, genetic screening, and embryo selection techniques are enhancing success rates and patient outcomes. Growing social acceptance of fertility treatments and delayed childbearing trends are further fueling market demand. Integration of personalized treatment plans and holistic care approaches is improving patient experiences and adherence.

Rising investments in reproductive health clinics and fertility research are supporting the expansion of the infertility treatment market globally. Technological innovations such as cryopreservation, stem cell therapies, and hormone modulation are creating new treatment opportunities. Government initiatives, insurance coverage, and reimbursement policies are making fertility treatments more accessible. Increasing collaboration between biotechnology companies and fertility centers is accelerating development of advanced therapies. With growing focus on reproductive wellness and technological advancements, the infertility treatment market is poised for steady growth.

Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/infertility-treatment-market?sp

Infertility Treatment Market: Major Players

CooperSurgical Inc, Vitrolife, FUJIFILM Irvine Scientific, Inc, Genea Limited, IVFtech ApS, Kitazato Corporation, Rocket Medical plc, Gynemedia, Boston IVF, Aspire Fertility.

Segment Covered in the Infertility Treatment Market:

➥ By Procedure: Assisted Reproductive Technology, In Vitro Fertilization, Intracytoplasmic Morphologically Selected Sperm Injection, Gamete Donation, Intracytoplasmic Sperm Injection, Surrogacy, Artificial Insemination, Intrauterine Insemination, Intracervical Insemination, Intratubal Insemination, Fertility Surgeries, Laparoscopy, Hysteroscopy, Myomectomy, Laparotomy, Tubal Ligation Reversal, Varicocelectomy, Microsurgical Reconstruction, Vasovasostomy, Vasoepididymostomy, Other Infertility Treatment Procedures

➥ By Product: Equipment, Microscopes, Imaging Systems, Sperm Analyzer Systems, Ovum Aspiration Pumps, Micromanipulator Systems, Incubators, Gas Analyzers, Laser Systems, Cryosystems, Sperm Separation Devices, Media & Consumables, Accessories

➥ By Patient Type: Female Infertility Treatment, Male Infertility Treatment

➥ By End-user: Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Research Institutes

Research Process:

Both primary and secondary data sources have been used in the Infertility Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Most Frequently Asked Questions in the Infertility Treatment Market Research Industry:

➠ Who leads the Infertility Treatment industry and what's their competitive positioning regarding capacity, performance, and profitability?
➠ What growth opportunities and market challenges do Infertility Treatment market vendors face?
➠ Which segments show the highest growth potential and market share distribution?
➠ What factors are driving or limiting Infertility Treatment market growth?
➠ What are the dominant sales and distribution strategies in the Infertility Treatment industry?

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=infertility-treatment-market

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Request for 2 Days FREE Trial Access:
https://www.datamintelligence.com/reports-subscription?sp

✅ Competitive Landscape
✅ Technology Roadmap Analysis
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Consumer Behavior & Demand Analysis
✅ Import-Export Data Monitoring
✅ Live Market & Pricing Trends

Have a look at our Subscription Dashboard:
https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release United States Infertility Treatment Market valuation $6,009.58 million by 2033 - Exclusive Report by DatamIntelligence here

News-ID: 4218102 • Views:

More Releases from DataM intelligence 4 Market Research LLP

Marfan Syndrome Treatment Market valuation $312.6 million by 2031 - Exclusive Report by DatamIntelligence
Marfan Syndrome Treatment Market valuation $312.6 million by 2031 - Exclusive Re …
"Global Marfan Syndrome Treatment Market reached US$ 203.5 million in 2023 and is expected to reach US$ 312.6 million by 2031, growing at a CAGR of 5.6% during the forecast period 2024-2031." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/marfan-syndrome-treatment-market?sp United States: Recent Industry Developments ✅ In September 2025, Roche launched a clinical trial for a new angiotensin receptor-neprilysin inhibitor targeting aortic dilation
United States Fetal Bovine Serum Market with CAGR of 5.3% during 2024-2031 - Exclusive Report by DatamIntelligence
United States Fetal Bovine Serum Market with CAGR of 5.3% during 2024-2031 - Exc …
"Fetal Bovine Serum Market size is estimated to reach at a high CAGR 5.3% during the forecast period 2024-2031." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/fetal-bovine-serum-market?sp United States: Recent Industry Developments ✅ In September 2025, Thermo Fisher Scientific launched a premium-grade Fetal Bovine Serum optimized for stem cell and regenerative medicine research. The serum offers consistent growth performance and enhanced cell viability. ✅
United States Menopause Treatment Market with CAGR of 8.8% during 2023-2030 - Exclusive Report by DatamIntelligence
United States Menopause Treatment Market with CAGR of 8.8% during 2023-2030 - Ex …
"Menopause Treatment Market is expected to grow at a CAGR of 8.8% during the forecasting period 2023-2030." As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/menopause-treatment-market?sp United States: Recent Industry Developments ✅ In September 2025, Pfizer launched an oral therapy targeting moderate-to-severe vasomotor symptoms in menopausal women. The treatment improves quality of life and provides a non-hormonal alternative. ✅ In August 2025, Amgen initiated a
United States Medical Billing Market to Reach USD 339.31 Billion by 2033, Driven by Healthcare Digitalization and AI Automation | DataM Intelligence
United States Medical Billing Market to Reach USD 339.31 Billion by 2033, Driven …
The global Medical Billing Market reached USD 122.21 billion in 2024 and is projected to reach USD 339.31 billion by 2033, growing at a CAGR of 12.1% during the forecast period 2025-2033, according to DataM Intelligence. United States: Recent Industry Developments ✅ In September 2025, The Centers for Medicare & Medicaid Services (CMS) implemented new automated billing codes for telehealth services, streamlining reimbursement processes. ✅ In August 2025, A major US healthcare

All 5 Releases


More Releases for Infertility

Shaping the Female Infertility Market in 2025: Rising Infertility Trends Driving …
How Big Is the Female Infertility Market Expected to Be, and What Will Its Growth Rate Be? In recent times, there has been a regular expansion in the market size of female infertility. The market is predicted to increase from $1.79 billion in 2024 to $1.87 billion in 2025, experiencing a compound annual growth rate (CAGR) of 4.5%. The reasons behind the growth during the historic period include the rising trend
Infertility Treatment Market - Unveiling the Path to Fulfillment: Transforming L …
Newark, New Castle, USA - new report, titled Infertility Treatment Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Infertility Treatment market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Infertility Treatment market. The report offers an overview of the market, which
Male Infertility Market Size Analysis, Industry Outlook, Regional Forecast 2021- …
Idiopathic infertility and varicocele infertility are the two most common types of male infertility. Surgery, treatment for intercourse issues, hormone treatment, and ART technologies are the most common therapies for male infertility. The global rate of infertility is steadily rising in both developed and developing countries. The global Male Infertility market size is projected to reach US$ 3773.8 million by 2027, from US$ 2738.4 million in 2020, at a CAGR
Infertility Drugs Market Increasing Research & Development for More Effective Tr …
Infertility is a global health issue as its affects both men and women. Infertility in females occur due to increasing age, polycystic ovarian syndrome (PCOS), obesity, and multiple miscarriages whereas in males infertility occur due to erectile dysfunction, low sperm count, abnormal sperms, etc. Increasing prevalence of infertility is expected to propel demand for the infertility drugs. According to World Health Organization (WHO) 2012 report, infertility affects one out of
Global Infertility Drug Pipeline Analysis
The market for reproductive medicine is experiencing a paradigm shift with new latest techniques being used and awareness among people increasing due to imparting knowledge about these techniques. The infertility drugs market promises significant room for growth. The market has high potential to scale up in order to meet the needs of infertile couples and also due to growth in reproductive tourism. Venture capitalists have entered the market by investing
Female Infertility-Pipeline Insights, 2017
This report helps to analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the Female Infertility-Pipeline Insights, 2017 “Female Infertility-Pipeline Insights, 2017”, report provides in depth insights on the pipeline drugs and their development activities around the Female Infertility. The Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III